Literature DB >> 29778128

The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic Patients.

Babalola Ishmael Afolabi1, Bolanle Olubunmi Ibitoye1, Rosemary Temidayo Ikem2, Adeleye Dorcas Omisore3, Bukunmi Michael Idowu1, David Olubukunmi Soyoye2.   

Abstract

BACKGROUND: Metabolic risk factors associated with non-alcoholic fatty liver disease (NAFLD) include Type 2 diabetes mellitus (T2DM), obesity and dyslipidaemia. Prevention or management of these risk factors with glycaemic control, weight reduction and low serum lipid levels respectively have been reported to reduce the risk of NAFLD or slow its progression. Since ultrasound (USS) is a safe and reliable method of identifying fatty changes in the liver, this study was done to determine the relationship between glycaemic control and ultrasound diagnosed NAFLD in T2DM.
METHODOLOGY: Demographic data, anthropometric measurements and laboratory tests including glycated haemoglobin (HbA1c), fasting blood glucose (FBG) and serum lipids of 80 T2DM subjects aged 40-80 years were taken. Their livers were evaluated using B-mode ultrasound, and the data obtained were statistically analysed using SPSS version 20.
RESULTS: Fifty-five of all participants (68.8%) were diagnosed with NAFLD sonographic grades 1, 2 and 3 made up of 13 (16.3%), 26 (32.5%) and 16 (20.0%), respectively while 25 (37.2%) had grade 0. The prevalence of NAFLD in T2DM varied significantly with BMI (p = 0.001) and glycaemic control (p = 0.048) while the USS grades of NAFLD varied significantly with age (p = 0.043) and BMI (p = 0.006). The independent strong predictors of NAFLD were overweight (r = 0.409, p = 0.012, OR = 6.626) and obesity (r = 0.411 p = 0.009, OR = 11.508), while poor glycaemic control (r = 0.270, p = 0.015, OR = 3.473) was a moderate independent predictor.
CONCLUSION: The prevalence of NAFLD increases with increasing BMI and HBA1c in T2DM, while its ultrasound grade varies with BMI. Overweight, obesity and poor glycaemic control are independent predictors of NAFLD.
Copyright © 2017 National Medical Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Body mass index; Diabetes mellitus; Glycaemic control; Lipids; Non-alcoholic fatty liver disease; Obesity

Mesh:

Substances:

Year:  2017        PMID: 29778128     DOI: 10.1016/j.jnma.2017.06.001

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  10 in total

1.  Glycaemic control among type 2 diabetes patients in sub-Saharan Africa from 2012 to 2022: a systematic review and meta-analysis.

Authors:  Jean-Pierre Fina Lubaki; Olufemi Babatunde Omole; Joel Msafiri Francis
Journal:  Diabetol Metab Syndr       Date:  2022-09-20       Impact factor: 5.395

2.  Liver steatosis and metabolic dysfunction-associated fatty liver disease among HIV-positive and negative adults in urban Zambia.

Authors:  Belinda Varaidzo Chihota; Carlotta Riebensahm; Guy Muula; Edford Sinkala; Roma Chilengi; Lloyd Mulenga; Samuel Bosomprah; Michael J Vinikoor; Carolyn Bolton-Moore; Matthias Egger; Andri Rauch; Annalisa Berzigotti; Gilles Wandeler
Journal:  BMJ Open Gastroenterol       Date:  2022-07

Review 3.  The burden and risks of emerging complications of diabetes mellitus.

Authors:  Dunya Tomic; Jonathan E Shaw; Dianna J Magliano
Journal:  Nat Rev Endocrinol       Date:  2022-06-06       Impact factor: 47.564

4.  Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex.

Authors:  Yasuhiro Matsubayashi; Kazuya Fujihara; Mayuko Yamada-Harada; Yurie Mitsuma; Takaaki Sato; Yuta Yaguchi; Taeko Osawa; Masahiko Yamamoto; Masaru Kitazawa; Takaho Yamada; Satoru Kodama; Hirohito Sone
Journal:  Cardiovasc Diabetol       Date:  2022-06-02       Impact factor: 8.949

Review 5.  Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management.

Authors:  Maja Cigrovski Berkovic; Lucija Virovic-Jukic; Ines Bilic-Curcic; Anna Mrzljak
Journal:  World J Gastroenterol       Date:  2020-06-07       Impact factor: 5.742

6.  Non-Alcoholic Fatty Liver Disease among Type-2 Diabetes Mellitus Patients in Abha City, South Western Saudi Arabia.

Authors:  Abdullah A Alsabaani; Ahmed A Mahfouz; Nabil J Awadalla; Mustafa Jafar Musa; Suliman M Al Humayed
Journal:  Int J Environ Res Public Health       Date:  2018-11-11       Impact factor: 3.390

7.  Non-alcoholic fatty liver disease in Africa: a hidden danger.

Authors:  Imran M Paruk; Fraser J Pirie; Ayesha A Motala
Journal:  Glob Health Epidemiol Genom       Date:  2019-04-12

Review 8.  NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment.

Authors:  Ming-Feng Xia; Hua Bian; Xin Gao
Journal:  Front Pharmacol       Date:  2019-08-06       Impact factor: 5.810

9.  Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial.

Authors:  Rasha R El-Kady; Amani K Ali; Lamia M El Wakeel; Nagwa A Sabri; May A Shawki
Journal:  Ther Adv Chronic Dis       Date:  2022-02-23       Impact factor: 5.091

10.  Assessment of fatty liver and its correlation with glycemic control in patients with type 2 diabetes mellitus attending Dessie Comprehensive Specialized Hospital, Northeast Ethiopia.

Authors:  Gashaw Abebe; Daniel Ayanaw; Tiget Ayelgn Mengstie; Gashaw Dessie; Tabarak Malik
Journal:  SAGE Open Med       Date:  2022-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.